Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$500,543,377
-$164,622,595 QoQ
Shares Held
1,970,876
-27.6% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
4.00%
of 13F equity value
Holder Rank
#99
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BAHL & GAYNOR INC holds $1,357,498,569 across 6 Drug Manufacturers - General names. JNJ ranks #2 (36.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
656,123 | $786,973,675 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,970,876 | $500,543,377 | |
| 3 | AMGN |
Amgen Inc
|
186,593 | $67,569,057 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
28,240 | $1,627,188 | |
| 5 | PFE |
Pfizer Inc
|
20,743 | $499,491 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,262 | $285,781 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $500,543,377 | 1,970,876 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $665,165,972 | 2,721,183 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $566,618,338 | 2,737,948 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $494,608,591 | 2,667,504 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $385,988,557 | 2,526,930 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $362,873,011 | 2,188,091 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $192,115,232 | 1,328,414 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $53,423,565 | 329,653 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $49,646,167 | 339,670 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $56,630,121 | 357,988 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $57,377,655 | 366,069 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $57,602,268 | 369,838 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $68,319,042 | 412,754 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $64,956,625 | 419,075 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $75,883,363 | 429,569 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $70,293,317 | 430,297 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $76,290,425 | 429,781 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $76,959,646 | 434,236 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $77,724,457 | 454,343 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $90,021,715 | 557,410 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $100,066,865 | 607,423 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $114,546,690 | 696,968 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $152,899,862 | 971,533 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $229,944,563 | 1,544,496 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $300,831,195 | 2,139,168 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $275,347,035 | 2,099,802 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||